1. A randomised evaluation of low‐dose Ara‐C plus pegylated recombinant arginase BCT‐100 versus low dose Ara‐C in older unfit patients with acute myeloid leukaemia: Results from the LI‐1 trial. (22nd November 2022) Authors: Mussai, Francis; De Santo, Carmela; Cheng, Paul; Thomas, Ian F.; Ariti, Cono; Upton, Laura; Scarpa, Ugo; Stavrou, Victoria; Sydenham, Mia; Burnett, Alan K.; Knapper, Steven K.; Mehta, Priyanka; McMullin, Mary F.; Copland, Mhairi; Russell, Nigel H.; Dennis, Mike Journal: British journal of haematology Issue: Volume 200:Number 5(2023) Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Targeting the arginine metabolic brake enhances immunotherapy for leukaemia. Issue 8 (11th January 2019) Authors: Mussai, Francis; Wheat, Rachel; Sarrou, Evgenia; Booth, Sarah; Stavrou, Victoria; Fultang, Livingstone; Perry, Tracey; Kearns, Pamela; Cheng, Paul; Keeshan, Karen; Craddock, Charles; De Santo, Carmela Journal: International journal of cancer Issue: Volume 145:Issue 8(2019) Page Start: 2201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗